Skip to main content
. 2023 Jan 31;13(1):e068652. doi: 10.1136/bmjopen-2022-068652

Figure 1.

Figure 1

Study flowvhart. The number of patients to be randomised and assigned to one of two treatment arms, on 1.0 mg semaglutide or matching placebo once a weel is 104, with an expected drop-out rate of up to 50% for the 26-week trial period. DXA, dual-energy X-ray absorption; PANSS-6, Positive and Negative Syndrome Scale–Six Items.